Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy

Abroad (travel likely)RecruitingPHASE2

Conditions

Ovarian Cancer · Ovarian Carcinoma, Recurrent · Ovarian Cancer Metastatic Recurrent · Ovarian Cancer (OvCa)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Yonsei University Health System, Severance Hospital, Seoul, Seoul, South Korea

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Solid Tumor, Adult · Colorectal Cancer · Non Small Cell Lung Cancer

Abroad (travel likely)Recruiting

Gilbert, United States · Phoenix, United States

Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer

Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1

Houston, United States

Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer

Ovarian Cancer

Abroad (travel likely)RecruitingPHASE2

Chicago, United States · Kelowna, Canada

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Breast Cancer · Endometrial Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orlando, United States · Boston, United States